CURE FOR ALZHEIMER’S DISEASE FOUND!

We are very close to developing an integrated suite of products that can immediately affect the quality and productivity of life for current Alzheimer’s and MCI patients.

“Not exactly, but we are very close to developing an integrated suite of products that can immediately affect the quality and productivity of life for current Alzheimer’s and MCI patients”, so says Michael R. Drapp (CEO) of Cognitive Science LLC.

Cognitive Science, founded by Michael R. Drapp (CEO) and Daniel Babcock (President), is an early-stage startup developing integrated technologies that can be used in conjunction or stand -alone mode with current pharmacological solutions.

“Our integrated approach allows us to customize the optimal balance of non-invasive technologies with the current regime prescribed by the patient’s caregivers,” says Michael Drapp. “Low cost, rapid deployment and IOT (Internet of Things) enabled technologies are key to widespread application, adoption and greater patient involvement. This is the primary focus of our product development that Dan and I envisioned; along with the latest medical and cognitive research.”